UID:
almahu_9949251234302882
Format:
1 online resource (XII, 492 p. 67 illus., 4 illus. in color.)
Edition:
1st ed. 2010.
ISBN:
9781607614166
Series Statement:
Methods in Molecular Biology, 596
Content:
With the devastating complication of cancer cells becoming simultaneously resistant to many structurally and mechanistically unrelated drugs, the efficacy of chemotherapeutic management of cancer often becomes severely limited. In Multi-Drug Resistance in Cancer, leading researchers in the field provide comprehensive and up-to-date reviews of multidrug resistance mechanisms, from over-expression of ATP-binding cassette drug transporters such as P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance protein, to the drug ratio-dependent antagonism and the paradigm of cancer stem cells. The extensive volume also includes strategies to overcome multidrug resistance, from the development of compounds that inhibit drug transporter function to the modulation of transporter expression, as well as techniques for detection and imaging of drug transporters, methods for investigation of drug resistance in animal models, and strategies to evaluate the efficacy of resistance reversal agents. As a volume in the highly successful Methods in Molecular Biology™ series, this work provides the kind of detailed description and implementation advice that is crucial for getting optimal results. Authoritative and cutting-edge, Multi-Drug Resistance in Cancer offers a state-of-art collection of reviews and methods for both basic and clinician investigators who are interested in the vital study of cancer multi-drug resistance mechanisms and reversal strategies.
Note:
Bibliographic Level Mode of Issuance: Monograph
,
Multidrug Resistance in Cancer -- Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets -- Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer -- Mechanisms of Multidrug Resistance in Cancer -- Molecular Mechanisms of Drug Resistance in Single-Step and Multi-Step Drug-Selected Cancer Cells -- Pharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications -- Flow Cytometric Evaluation of Multidrug Resistance Proteins -- Targeted Chemotherapy in Drug-Resistant Tumors, Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer, and Emerging Role of Pgp in Neurodegenerative Diseases -- Epigenetic Regulation of Multidrug Resistance 1 Gene Expression: Profiling CpG Methylation Status Using Bisulphite Sequencing -- Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics -- Molecular Mechanism of ATP-Dependent Solute Transport by Multidrug Resistance-Associated Protein 1 -- Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes -- Drug Ratio-Dependent Antagonism: A New Category of Multidrug Resistance and Strategies for Its Circumvention -- Reversing Agents for ATP-Binding Cassette Drug Transporters -- Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors -- Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation -- Examination of CYP3A and P-Glycoprotein-Mediated Drug–Drug Interactions Using Animal Models -- Generating Inhibitors of P-Glycoprotein: Where to, Now? -- Immunosuppressors as Multidrug Resistance Reversal Agents -- Overcoming Multidrug Resistance by RNA Interference -- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology.
,
English
Additional Edition:
ISBN 1-60761-416-2
Additional Edition:
ISBN 1-60761-415-4
Language:
English
DOI:
10.1007/978-1-60761-416-6
Bookmarklink
